MEDTRONIC ADAPTA, VERSA AND SENSIA nEw3 POST APPROVAL STUDY

CompletedOBSERVATIONAL
Enrollment

2,927

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

October 31, 2015

Study Completion Date

December 31, 2015

Conditions
ArrhythmiaBradycardia
Trial Locations (129)

Unknown

Birmingham

Anchorage

Gilbert

Scottsdale

Jonesboro

Little Rock

Bakersfield

Chula Vista

Downey

East Palo Alto

La Jolla

Long Beach

Los Angeles

Redding

Salinas

San Diego

Santa Rosa

Torrance

Van Nuys

Colorado Springs

Denver

Newark

Washington D.C.

Bradenton

Clearwater

Jacksonville

Melbourne

Tampa

Albany

Atlanta

Columbus

Marietta

Oak Lawn

Evansville

Indianapolis

Des Moines

Kansas City

Edgewood

Lexington

Louisville

Alexandria

Baton Rouge

Covington

Salisbury

Silver Spring

Takoma Park

Towson

Worcester

Lansing

Marquette

Saginaw

Ypsilanti

Coon Rapids

Minneapolis

Robbinsdale

Rochester

Saint Louis Park

Saint Paul

Columbia

Kansas City

Washington

Lebanon

Browns Mills

Ocean City

Parlin

West Orange

Albuquerque

Garden City

Henderson

Huntington

Poughkeepsie

Rochester

Utica

Durham

Greensboro

Raleigh

Winston-Salem

Fargo

Akron

Cincinnati

Cleveland

Columbus

Toledo

Portland

Erie

Lancaster

Sayre

Charleston

Columbia

Florence

Sioux Falls

Chattanooga

Germantown

Kingsport

Nashville

Austin

Dallas

Fort Worth

Houston

Plano

San Antonio

The Woodlands

Burlington

Chesapeake

Fairfax

Olympia

Spokane

Tacoma

Madison

Milwaukee

Linz

Hasselt

Calgary

Kingston

Ottawa

Toronto

Montreal

Regina

Copenhagen

Marseille

Nantes

Homburg/Saar

Reggio Emilia

Udine

Eindhoven

Rotterdam

Belgrade

Skövde

Zurich

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medtronic

INDUSTRY